Bimeda UK has announced that Endofluke 100mg Oral Suspension (VM No. 12597/4037) has now been approved for use in dairy cows, with a milk withdrawal period of 45 days + 48 hours.
Endofluke is licensed for use in cattle and sheep and its active ingredient, triclabendazole (100mg/ml), is the only active proven to kill all three stages of liver fluke.
Bimeda UK sales manager Andrew Lane said: “This is great news for the UK’s dairy farmers. Endofluke has long been favoured by British and Northern Irish farmers as a liver fluke treatment due to its ability to offer complete chronic and acute fluke control in both sheep and cattle. It is proven to be highly effective against early-immature, immature and adult liver fluke, and to now be able to extend these benefits to dairy cows, is fantastic news for the UK’s dairy farmers.”
Bimeda’s commercial vet Padraig Hyland added: “We are extremely happy to be able to now provide this tried and trusted fluke treatment to the UK’s dairy farmers.”